EMAN · Emagin Corp - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.96M | $6.59M | - | $7.62M | $7.16M | $7.36M | - | $5.78M | $6.28M | $6.77M |
| Cost of Revenue | $5.46M | $5.12M | - | $4.77M | $5.59M | $4.87M | - | $5.22M | $5.71M | $5.07M |
| Gross Profit | ($507.0K) | $1.47M | - | $2.85M | $1.57M | $2.49M | - | $559.0K | $571.0K | $1.71M |
| R&D | $1.64M | $1.20M | - | $1.24M | $1.46M | $1.48M | - | $1.67M | $1.79M | $1.84M |
| SG&A | $9.02M | $2.81M | - | $1.73M | $1.90M | $2.17M | - | $2.20M | $1.69M | $1.82M |
| Total Operating Expenses | $10.66M | $4.01M | - | $2.96M | $3.36M | $3.65M | - | $3.87M | $3.48M | $3.67M |
| D&A | - | $734.0K | - | - | - | $722.0K | - | - | - | $733.0K |
| Operating Income | ($11.17M) | ($2.53M) | - | ($109.0K) | ($1.79M) | ($1.17M) | - | ($3.31M) | ($2.91M) | ($1.96M) |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | - | - | - | - | - | - | - | - | - | - |
| Net Income | ($11.17M) | ($2.62M) | - | ($334.0K) | ($1.44M) | ($137.0K) | - | $1.31M | ($278.0K) | ($7.38M) |
| EPS - Basic | ($0.13) | ($0.03) | - | - | ($0.02) | ($0.10) | - | ($0.06) | - | - |
| EPS - Diluted | ($0.13) | ($0.03) | - | - | $0.00 | ($0.10) | - | ($0.05) | - | - |
Balance Sheet
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.26M | $3.85M | $4.35M | $3.86M | $4.29M | $3.86M | $5.72M | $7.34M | $5.45M | $3.14M |
| Accounts Receivable | $3.91M | $5.51M | $7.04M | $5.09M | $5.02M | $4.34M | $4.49M | $4.34M | $3.12M | $4.42M |
| Inventory | $9.02M | $8.80M | $8.71M | $8.33M | $7.66M | $8.17M | $7.63M | $7.92M | $8.13M | $8.41M |
| Accounts Payable | $2.64M | $1.20M | $2.08M | $1.52M | $1.16M | $3.96M | $1.35M | $988.0K | $1.43M | $1.27M |
| Current Assets | $20.61M | $21.82M | $23.93M | $20.35M | $19.84M | $21.23M | $20.73M | $22.97M | $24.96M | $26.78M |
| Total Assets | $73.18M | $73.06M | $73.11M | $59.96M | $57.45M | $58.27M | $51.37M | $52.36M | $50.62M | $49.05M |
| Current Liabilities | $9.99M | $5.77M | $6.96M | $6.45M | $7.49M | $9.81M | $8.94M | $11.86M | $15.98M | $18.51M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $61.53M | $50.46M | $49.31M | $39.49M | $38.35M | $39.54M | $33.12M | $35.60M | $35.59M | $34.75M |
| Stockholders' Equity | $11.66M | $22.60M | $23.80M | $20.47M | $19.11M | $18.73M | $18.24M | $16.76M | $15.03M | $14.30M |
| Retained Earnings | ($272.16M) | ($260.99M) | ($258.37M) | ($259.18M) | ($258.84M) | ($257.40M) | ($257.26M) | ($258.41M) | ($259.71M) | ($259.44M) |
Cash Flow
| Line item | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($167.0K) | - | - | - | ($128.0K) | - | - | - | ($1.15M) |
| Investing Cash Flow | - | ($2.80M) | - | - | - | ($7.07M) | - | - | - | ($1.71M) |
| Financing Cash Flow | - | $2.47M | - | - | - | $5.40M | - | - | - | $4.81M |
| CapEx | - | - | - | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - | - | - | - |
Ratios
| Metric | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | -10.2% | 22.4% | - | 37.5% | 21.9% | 33.8% | - | 9.7% | 9.1% | 25.2% |
| Operating margin | -225.3% | -38.4% | - | -1.4% | -25.0% | -15.8% | - | -57.3% | -46.3% | -28.9% |
| EBITDA margin | - | -27.3% | - | - | - | -6.0% | - | - | - | -18.1% |
| Net margin | -225.4% | -39.7% | - | -4.4% | -20.1% | -1.9% | - | 22.6% | -4.4% | -108.9% |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | - | - | - | - | - | - | - | - | - | - |
| R&D / Revenue | 33.1% | 18.2% | - | 16.2% | 20.4% | 20.2% | - | 28.9% | 28.5% | 27.2% |
| SG&A / Revenue | 182.1% | 42.5% | - | 22.7% | 26.6% | 29.5% | - | 38.1% | 26.9% | 26.9% |
| Effective tax rate | - | - | - | - | - | - | - | - | - | - |
| Return on assets | -15.3% | -3.6% | - | -0.6% | -2.5% | -0.2% | - | 2.5% | -0.5% | -15.0% |
| Return on equity | -95.8% | -11.6% | - | -1.6% | -7.5% | -0.7% | - | 7.8% | -1.8% | -51.6% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 2.06 | 3.78 | 3.44 | 3.15 | 2.65 | 2.16 | 2.32 | 1.94 | 1.56 | 1.45 |
| Quick ratio | 1.16 | 2.26 | 2.19 | 1.86 | 1.63 | 1.33 | 1.47 | 1.27 | 1.05 | 0.99 |
| Cash ratio | 0.33 | 0.67 | 0.62 | 0.60 | 0.57 | 0.39 | 0.64 | 0.62 | 0.34 | 0.17 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 6.28 | 3.23 | 3.07 | 2.93 | 3.01 | 3.11 | 2.82 | 3.12 | 3.37 | 3.43 |
| Liabilities / Assets | 0.84 | 0.69 | 0.67 | 0.66 | 0.67 | 0.68 | 0.64 | 0.68 | 0.70 | 0.71 |
| Efficiency | ||||||||||
| Asset turnover | 0.07 | 0.09 | - | 0.13 | 0.12 | 0.13 | - | 0.11 | 0.12 | 0.14 |
| Inventory turnover | 0.61 | 0.58 | - | 0.57 | 0.73 | 0.60 | - | 0.66 | 0.70 | 0.60 |
| Days sales outstanding | 288d | 305d | - | 244d | 256d | 215d | - | 274d | 181d | 238d |
| Days inventory outstanding | 603d | 628d | - | 638d | 500d | 612d | - | 553d | 520d | 606d |
| Days payable outstanding | 177d | 85d | - | 117d | 76d | 297d | - | 69d | 91d | 91d |
| Cash conversion cycle | 714d | 847d | - | 765d | 680d | 530d | - | 759d | 610d | 753d |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | -30.8% | -10.4% | - | 31.8% | 14.0% | 8.6% | - | -20.9% | -18.5% | 0.6% |
| Revenue CAGR (3y) | -13.7% | -0.7% | - | -1.3% | 10.1% | 6.4% | - | 10.5% | -3.9% | 3.7% |
| Revenue CAGR (5y) | -6.9% | 1.7% | - | 12.2% | 6.4% | 3.9% | - | 6.1% | 2.6% | -0.7% |
| Gross profit growth (YoY) | - | -40.8% | - | 410.7% | 174.8% | 45.7% | - | -67.0% | -71.1% | 19.1% |
| Operating income growth (YoY) | -523.1% | -117.5% | - | 96.7% | 38.4% | 40.5% | - | -77.5% | -117.8% | -45.7% |
| Net income growth (YoY) | -675.7% | -1813.1% | - | - | -418.0% | 98.1% | - | - | 90.2% | -438.9% |
| EPS growth (YoY) | - | 70.0% | - | - | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -39.0% | 20.6% | 30.4% | 22.2% | 27.1% | 31.0% | 12.3% | -16.0% | -11.3% | -20.3% |
Peer comparison
Same SIC group: Semiconductors & Related Devices
Comparing EMAGIN CORP against the 5 most active filers in the same SIC group.